Anchiano Therapeutics Ltd. (NASDAQ: ANCN)


Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the merger of ANCN with Chemomab Ltd.  ANCN shareholders will only receive 10% of the combined company.

If you are a ANCN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com .

BioTelemetry, Inc. (NASDAQ: BEAT)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of BEAT to Royal Philips for $72.00 per share.

If you are an investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780.

HMS Holdings Corp. (NASDAQ: HMSY)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of HMSY to Gainwell Technologies for $37.00 per share.

If you are a HMSY investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780.

Seneca Biopharma, Inc. (NASDAQ CM: SNCA)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with SNCA’s agreement to merge with Leading BioSciences, Inc.

If you are a SNCA investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com .

Sportsman’s Warehouse Holdings, Inc. (NASDAQ GS: SPWH)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of SPWH to affiliates of the Great American Outdoors Group for $18.00 per share.

If you are a SPWH investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com .

TC PipeLines, LP (NYSE: TCP) – TC Energy Corporation (NYSE: TRP)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of TCP to TRP for 0.70 TRP common shares per unit.

If you are a investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com .

Tilray, Inc. (NASDAQ: TLRY) – Aphria Inc. (NASDAQ: APHA)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the merger of APHA with TLRY for 0.8381 TLRY shares per share.

If you are an investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com .

ATTORNEY ADVERTISING. © 2020 Lifshitz Law Firm, P.C.  The law firm responsible for this advertisement is Lifshitz Law Firm, P.C., 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz Law Firm, P.C.
Phone:  516-493-9780

Facsimile: 516-280-7376
Email: info@jlclasslaw.com

Cision View original content: http://www.prnewswire.com/news-releases/lifshitz-law-firm-pc-announces-investigation-of-ancn-beat-hmsy-snca-spwh-tcp-trp-tlry-and-apha-301198476.html

SOURCE Lifshitz Law Firm

News Provided by PR Newswire via QuoteMedia

In the cannabis space this week, retailer Fire & Flower Holdings (TSX:FAF,OTCQX:FFLWF) told investors it will be entering the US market through a novel strategic action.

Meanwhile, two longstanding cannabis partners ended their relationship.

Keep reading... Show less

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less